MarketPeel
Insider Trading Intelligence
Chief Scientific Officer
Mon, Jun 29, 2026
Jun 29
sold $235.77k of CADL
23,447 shares @ $10.06
Decreased holdings by -23.30%
2nd largest trade (out of 19)
Planned (10b5-1)Positive 90D History
This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
67% win rate · +9.0% median edge vs SPY (6 trades, 90-day · small sample)
Price 72% above 200-day moving average
Small Cap stock — insider trades carry more weight
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
CADLCandel Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W+12.03%
1M+37.34%
3M
6M
1Y

Recent insider activity at CADL

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback